REFERENCES
1. Bennewitz H. De Diabete Mellito, Graviditatis Symptomate. University of Berlin, 1824.
2. Farquhar. J.W. The child of the diabetic woman. Arch Dis Child. 1959; 34 (173): 76–96. DOI: https://doi.org/10.1136/adc.34.173.76
3. O’Sullivan J.B., Mahan C.M. Criteria for the oral glucose tolerance test in pregnancy. Diabetes. 1964; 13: 278–85.
4. Mestman J.H., Anderson G.V., Barton P. Carbohydrate metabolism in pregnancy. A study of 658 patients with the use of the oral glucose tolerance test and the prednisolone glucose tolerance test. Am J Obstet Gynecol. 1971; 109 (1): 41–5.
5. American College of Obstetricians and Gynecologists. Management of diabetes mellitus in pregnancy. Technical Bulletin No. 48. Washington, DC: ACOG, 1978.
6. Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. National Diabetes Data Group. Diabetes. 1979; 28 (12): 1039-57.
7. WHO Expert Committee on Diabetes Mellitus: second report. World Health Organ Tech Rep Ser. 1980; 646: 1-80.
8. Metzger B., Oats J., Coustan D. Hod Results of the HAPO study: progress towards a new paradigm for detection & diagnosis of GDM. In: 5th International Simposium on Diabetes and Pregnancy. Sorrento, Italy, 2009: 640 p.
9. WHO. Diagnostic criteria and classification of hyperglycaemia first detected in pregnancy. World Health Organization, 2013.
10. Russian Association of Endocrinologists, Russian Society of Obstetricians and Gynecologists. Gestational diabetes. Diagnosis, treatment, obstetric tactics, postpartum care. Clinical guidelines. Moscow, 2020. (in Russian)
11. International Diabetes Federation (IFA). Diabetic Atlas. 9th ed. 2019.
12. Dedov I.I., Mel’nichenko G.A., Shestakova M.V., et al. Russian national clinical recommendations for morbid obesity treatment in adults. 3rd revision (morbid obesity treatment in adults). Ozhirenie i metabolism [Obesity and Metabolism]. 2018; 15 (1): 53-79. (in Russian)
13. Lavery J.A., Friedman A.M., Keyes K.M., Wright J.D., Ananth C.V. Gestational diabetes in the United States: temporal changes in prevalence rates between 1979 and 2010. BJOG. 2017; 124 (5): 804-13. DOI: https://doi.org/10.1111/1471-0528.14236
14. Dos Santos P.A., Madi J.M., da Silva E.R., Vergani D.O.P., de Araujo B.F., Garcia R.M.R. Gestational diabetes in the population served by Brazilian Public Health Care. Prevalence and risk factors. Rev Bras Ginecol Obstet. 2020; 42 (1): 12-8. DOI: https://doi.org/10.1055/s-0039-1700797
15. Mc Guane J.T., Grlj L., Peek M.J. Obesity, gestational diabetes and macro-somia are associated with increasing rates of early-term induction of labour at the Canberra Hospital. Aust N Z J Obstet Gynaecol. 2019; 59 (2): 215-20. DOI: https://doi.org/10.1111/ajo.12820
16. Kapustin R.V., Onopriychuk A.R., Arzhanova O.N., et al. Pathophysiology of placenta and fetus in diabetes mellitus. Zhurnal akusherstva i zhenskikh bolezney [Journal of Obstetrics and Women’s Diseases]. 2018; 67 (6): 79-92. (in Russian)
17. Scholtens D.M., Kuang A., Lowe L.P., Hamilton J., Lawrence J.M., Lebenthal Y., et al. Hyperglycemia and Adverse Pregnancy Outcome Follow-up Study (HAPO FUS): maternal glycemia and childhood glucose metabolism. Diabetes Care. 2019; 42 (3): 381-92. DOI: https://doi.org/10.2337/dc18-2021.
18. Abramova M.E., Khodzhaeva Z.S., Gorina K.A., Muminova K.T., Goryunov K.V., Ragozin A.K., Silachev D.N. Gestational diabetes mellitus: screening and diagnostic criteria in early pregnancy. Akusherstvo i ginekologiya [Obstetrics and Gynecology]. 2021; (5): 25-32. DOI: https://dx.doi.org/10.18565/aig.2021.5.25-32 (in Russian)
19. Li X., Zhang W., Lin J., Liu H., Yang Z., Teng Y., et al. Risk factors for adverse maternal and perinatal outcomes in women with preeclampsia: analysis of 1396 cases. J Clin Hypertens. (Greenwich). 2018; 20 (6): 1049-57. DOI: https://doi.org/10.1111/jch.13302
20. Szmuilowicz E.D., Josefson J.L., Metzger B.E. Gestational diabetes mel-litus. Endocrinol Metab Clin North Am. 2019; 48 (3): 479-93. DOI: https://doi.org/10.1016/j.ecl.2019.05.001
21. Brown J., Grzeskowiak L., Williamson K., Downie M.R., Crowther C.A. Insulin for the treatment of women with gestational diabetes. Cochrane Database Syst Rev. 2017; 11: CD012037. DOI: https://doi.org/10.1002/14651858.CD012037.pub2
22. Committee on Practice Bulletins - Obstetrics ACOG practice bulletin No 190: gestational diabetes mellitus. Obstet Gynecol. 2018; 131 (2): e49-64.
23. Berger H., Gagnon R., Sermer M., Basso M., Bos H., Brown R.N., et al. Diabetes in pregnancy. J Obstet Gynaecol Can. 2016; 38 (7): 667-79. DOI: https://doi.org/10.1016/j.jogc.2016.04.002
24. Gestational Diabetes. Current Care Guidelines. Working group set up by the Finnish Medical Society Duodecim, the Finnish Diabetes Associations Medical Advisory Board, a the Finnish Society of Obstetrics and Gynaecology. Helsinki: The Finnish Medical Society Duodecim, 2013.
25. American Diabetes Association. Classification and diagnosis of diabetes: standards of medical care in diabetes - 2020. Diabetes Care. 2020; 43 (suppl 1): S14-31. DOI: https://dx.doi.org/10.2337/dc20-S002
26. Yang H.X. Diagnostic criteria for gestational diabetes mellitus (WS 331-2011). Chin Med J. (Engl). 2012; 125 (7): 1212-3.
27. Seshiah V., Balaji V., Shah S.N., Joshi S., Das A.K., Sahay B.K., et al. Diagnosis of gestational diabetes mellitus in the community. J Assoc Physicians India. 2012; 60: 15-7.
28. Hod M., Kapur A., Sacks D.A., Hadar E., Agarwal M., Di Renzo G.C., et al. The International Federation of Gynecology and Obstetrics (FIGO) Initiative on gestational diabetes mellitus: a pragmatic guide for diagnosis, management, and care. Int J Gynaecol Obstet. 2015; 131 (suppl 3): S173-211. DOI: https://doi.org/10.1016/S0020-7292(15)30033-3
29. Radzinskiy V.E., Botasheva T.L., Papysheva O.V. etc. Obesity. Diabetes. Pregnancy. versions and counterversions. Clinical practices. Perspectives. Moscow: GEOTAR-Media, 2020: 528 p. DOI: https://doi.org/10.33029/9704-5442-8-OBE-2020-1-528 (in Russian)
30. Zhu W.W., Yang H.X., Wei Y.M., Yan J., Wang Z.L., Li X.L., et al. Evaluation of the value of fasting plasma glucose in the first prenatal visit to diagnose gestational diabetes mellitus in China. Diabetes Care. 2013; 36 (3): 586-90. DOI: https://doi.org/10.2337/dc12-1157
31. Wang C., Zhu W., Wei Y., Su R., Feng H., Lin L., et al. The predictive effects of early pregnancy lipid profiles and fasting glucose on the risk of gestational diabetes mellitus stratified by body mass index. J Diabetes Res. 2016; 2016: 3013567. DOI: https://doi.org/10.1155/2016/3013567
32. Meek C.L., Murphy H.R., Simmons D. Random plasmaglucose in early pregnancy is a better predictor of gestational diabetes diagnosis than maternal obesity. Diabetologia. 2016; 59 (3): 445-52. DOI: https://doi.org/10.1007/s00125-015-3811-5
33. Harreiter J., Simmons D., Desoye G., Corcoy R., Adelantado J.M., Devli-eger R., et al. IADPSG and WHO 2013 gestational diabetes mellitus criteria identify obese women with marked insulin resistance in early pregnancy. Diabetes Care. 2016; 39 (7): e90-2. DOI: https://doi.org/10.2337/dc16-0200
34. Mane L., Flores-Le Roux J.A., Pedro-Botet J., Gortazar L., Chillaron J.J., Llau-rado G., et al. Is fasting plasma glucose in early pregnancy a better predictor of adverse obstetric outcomes than glycated haemoglobin? Eur J Obstet Gynecol Reprod Biol. 2019; 234: 79-84. DOI: https://doi.org/10.1016/j.ejogrb.2018.12.036
35. Fong A., Serra A.E., Gabby L., Wing D.A., Berkowitz K.M. Use of hemoglobin A1c as an early predictor of gestational diabetes mellitus. Am J Obstet Gynecol. 2014; 211 (6): 641.E1-7. DOI: https://doi.org/10.1016/j.ajog.2014.06.016
36. Adam S., Rheeder P. Selective screening strategies for gestational diabetes: a prospective cohort observational study. J Diabetes Res. 2017; 2017: 2849346. DOI: https://doi.org/10.1155/2017/2849346
37. Odsaeter I.H., Asberg A., Vanky E., et al. Hemoglobin A1c as screening for gestational diabetes mellitus in Nordic Caucasian women. Diabetol Metab Syndr. 2016; 8: 43. DOI: https://doi.org/10.1186/s13098-016-0168-y
38. Saprina T.V., Timokhina E.S., Vorozhtsova I.N. Glycated hemoglobin test: diagnostic difficulties in gestational diabetes. Sakharniy diabet [Diabetes Mellitus]. 2012; (4): 63-8. DOI: https://doi.org/10.14341/2072-0351-5540 (in Russian)
39. Hashimoto K., Koga M. Indicators of glycemic control in patients with gestational diabetes mellitus and pregnant women with diabetes mellitus. World J Diabetes. 2015; 6 (8): 1045-56. DOI: https://doi.org/10.4239/wjd.v6.i8.1045 PMID: 26240701; PMCID: PMC4515444.
40. White S.L., Lawlor D.A., Briley A.L., Godfrey K.M., Nelson S.M., et al. Early antenatal prediction of gestational diabetes in obese women: development of prediction tools for targeted intervention. PLoS One. 2016; 11 (12): e0167846.
41. Holodova E.A., Zabarovskaja Z.V., Pavljukova S.A. Level of glycated proteins in women with gestational diabetes mellitus. MEDICA. 2012; 70 (15): 106-9. (in Russian)
42. Cahill A.G., Tuuli M.G., Colvin R., Cade W.T., Macones G.A. Markers of glycemic control and neonatal morbidity in high-risk insulin-resistant pregnancies. Am J Perinatol. 2016; 33 (2): 151-6. DOI: https://doi.org/10.1055/s-0035-1562929 Epub 2015 Sep 2. PMID: 26332585.
43. Dereke J., Nilsson C., Strevens H., Landin-Olsson M., Hillman M. Pregnancy-associated plasma protein-A2 levels are increased in early-pregnancy gestational diabetes: a novel biomarker for early risk estimation. Diabet Med. 2020; 37 (1): 131-7. DOI: https://doi.org/10.1111/dme.14088 Epub 2019 Aug 14. PMID: 31340069.
44. Alamolhoda S.H., Yazdkhasti М., Namdari M., Zakariayi S.J., Mirabi P. Association between C-reactive protein and gestational diabetes: a prospective study. J Obstet Gynaecol. 2020; 40 (3): 349-53. DOI: https://doi.org/10.1080/01443615.2019.1631767
45. Ma D., Luque-Fernandez M.A., Bogdanet D., Desoye G., Dunne F., Hal-perin J.A. Plasma glycated CD59 predicts early gestational diabetes and large for gestational age newborns. J Clin Endocrinol Metab. 2020; 105 (4): e1033-40. DOI: https://doi.org/10.1210/clinem/dgaa087